Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.
about
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio LinfomiAdvances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategiesEvidence-based management of Hodgkin's disease: the role of autologous stem cell transplantation.Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma.Hodgkin's lymphoma therapy: past, present, and future.Should involved-field radiation therapy be used as an adjunct to lymphoma autotransplantation?Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites.Approach to Hodgkin's lymphoma in the new millennium.The Management of Classical Hodgkin's Lymphoma: Past, Present, and FutureIfosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: a children's oncology group reportDietary factors and the risk of endometrial cancer: a case--control study in Greece.High-dose chemotherapy and autologous bone marrow transplant in relapsed Hodgkin's disease--a pragmatic prognostic index.Stem cell transplantation in Hodgkin lymphoma.Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-upHigh-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin's Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation StudyCD30: an important new target in hematologic malignancies.Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management.New strategies in Hodgkin lymphoma: better risk profiling and novel treatments.Classical Hodgkin's lymphoma: past, present and future perspectives.Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management.Improving Outcome of Hodgkins Disease with Autologous Hematopoietic Stem Cell Transplantation.Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.Identification of risk factors in patients treated for first relapse of Hodgkin's disease.Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).Outcome of autologous hematopoietic stem cell transplantation in children and adolescents with relapsed or refractory Hodgkin's lymphoma.Advances in autologous stem cell transplantation.Primary Epstein-Barr virus infection diffusing F18-fluorodeoxyglucose-positron emission tomography/computed tomography response monitoring of Hodgkin's disease: a case report.Sequential combination of gemcitabine, vinorelbine, pegylated liposomal doxorubicin and brentuximab as a bridge regimen to transplant in relapsed or refractory Hodgkin lymphoma.Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution.Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy.A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation.High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors.Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma.Outcome analysis of high-dose chemotherapy and autologous stem cell transplantation in adolescent and young adults with relapsed or refractory Hodgkin lymphoma.Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systems.Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival.High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.
P2860
Q28186766-CA5E28C2-2C62-4D2A-9481-EB69E1E7FBD0Q33886267-C57541C8-2AA4-4C42-8969-707BD0D46D93Q33930383-2A24B9F2-365A-4652-BFE5-77F42168D06DQ34095620-92ED1912-88FE-4311-B104-86BDDA42EC7EQ34296914-6317706A-691D-482F-9E10-B2E9FCC79D37Q34541079-0D6282F5-D6AF-4328-A788-2B3AAA9CC617Q34548300-25C5418C-39D7-4F16-AECB-2E344E257CF7Q34580600-1D9D6235-18C9-4180-A330-1464391A08AFQ35038852-46FB1DAF-D7ED-437C-99E4-368C7D21F261Q35735986-E0DD3A7E-653F-4738-B0D2-CD59A5BDB24EQ36135255-2CD8043A-DBA1-4680-A4DC-7B77DA54BF7EQ36135259-EF492E64-941C-47D2-A4EB-AF11DCA98D18Q36752029-96BAEF6A-954E-4333-AAB9-3A0029A18E80Q37146056-52700629-FEC2-4605-B6F6-54B0507C0B67Q37238152-A72F7562-8415-4786-9F60-0D20598B7FE2Q37548240-74D7C451-02DF-4451-9FA4-47BFBC1BC5AFQ37880873-EC0D454D-4312-4608-84E1-48B520D0CD6AQ38059817-C4D93A37-EECB-444F-BB21-D0C2A368E77DQ38085250-61F2403D-00D7-4EAA-B446-CACFA3401633Q38162057-37875F91-4E42-4644-8BED-F2E2C9064AB1Q38784099-A8F897B6-25D0-4A27-8025-EA2866EC7A14Q38955399-DEA6AD16-8F56-49AC-B51B-6926AD005D7CQ39381251-4EC4545B-7681-4A29-8A1C-3597D70BA41FQ40599134-CED19CBF-3B1F-4488-84BB-729911CF7604Q40712492-595E91DB-B91E-4A24-9C22-3B8CD8D818A2Q41395870-7D32FF47-61B9-433C-85CF-8659FFA8B82DQ41669396-6B7AA3F9-656D-4220-9031-5C4C6A6556AFQ41850200-19767FAB-225E-4225-AF6D-D98064DACB6EQ42384513-600DB46A-59A8-4EEE-9F90-575FF57FDA82Q42433067-D04C389D-C904-40B3-912F-0ADF86134370Q43591852-8985945C-5D88-4741-979F-294286757C96Q43918953-DFDFEB24-EA98-4901-B207-DBD726EE8F8AQ44103047-2F18532F-FBA6-4241-9225-8E285005BB22Q44780860-35586D51-54BB-4ADE-A5D0-F5D2C5237635Q46738172-4A08699D-D7BE-4B8E-A87D-2B74D98B7BC7Q50880574-32165A4A-F7D6-470D-890D-31D099A6877FQ53326637-368DE29B-0466-4372-8D3B-9B39DB5C9B46Q53899679-E7DB712F-CB1A-4E54-9ADB-53212FCE7C79Q53963138-C93A59D7-B8D8-4AC7-967C-420820B1489CQ53965804-5C87C6C8-BAC4-4147-BA0E-DBB1C476330E
P2860
Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Conventional-dose salvage comb ...... the low probability for cure.
@en
Conventional-dose salvage comb ...... the low probability for cure.
@nl
type
label
Conventional-dose salvage comb ...... the low probability for cure.
@en
Conventional-dose salvage comb ...... the low probability for cure.
@nl
prefLabel
Conventional-dose salvage comb ...... the low probability for cure.
@en
Conventional-dose salvage comb ...... the low probability for cure.
@nl
P2093
P1476
Conventional-dose salvage comb ...... the low probability for cure.
@en
P2093
E Glatstein
J C Phares
P L Duffey
S M Hubbard
V T DeVita
P304
P356
10.1200/JCO.1992.10.2.210
P407
P577
1992-02-01T00:00:00Z